DOP2003000791A - INTERMEDIATE OF ACCEPTABLE NON-HYGROSCOPIC FORMULATION THAT INCLUDES A HYGROSCOPIC PHARMACO - Google Patents

INTERMEDIATE OF ACCEPTABLE NON-HYGROSCOPIC FORMULATION THAT INCLUDES A HYGROSCOPIC PHARMACO

Info

Publication number
DOP2003000791A
DOP2003000791A DO2003000791A DO2003000791A DOP2003000791A DO P2003000791 A DOP2003000791 A DO P2003000791A DO 2003000791 A DO2003000791 A DO 2003000791A DO 2003000791 A DO2003000791 A DO 2003000791A DO P2003000791 A DOP2003000791 A DO P2003000791A
Authority
DO
Dominican Republic
Prior art keywords
hygroscopic
pharmaco
formulation
acceptable non
polymer
Prior art date
Application number
DO2003000791A
Other languages
Spanish (es)
Inventor
Danchen Gao
Ann M Czyzewski
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Priority to DO2003000791A priority Critical patent/DOP2003000791A/en
Publication of DOP2003000791A publication Critical patent/DOP2003000791A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona una composición particulada sólida que comprende un fármaco higroscópico y/o delicuescente y al menos un polímero no higroscópico. El fármaco y el por menos un el polímero esta en asiciación íntima y la composición es aceptablemente no higroscópica.A solid particulate composition is provided comprising a hygroscopic and / or deliquescent drug and at least one non-hygroscopic polymer. The drug and the at least one polymer is in intimate association and the composition is acceptably non-hygroscopic.

DO2003000791A 2003-12-17 2003-12-17 INTERMEDIATE OF ACCEPTABLE NON-HYGROSCOPIC FORMULATION THAT INCLUDES A HYGROSCOPIC PHARMACO DOP2003000791A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2003000791A DOP2003000791A (en) 2003-12-17 2003-12-17 INTERMEDIATE OF ACCEPTABLE NON-HYGROSCOPIC FORMULATION THAT INCLUDES A HYGROSCOPIC PHARMACO

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2003000791A DOP2003000791A (en) 2003-12-17 2003-12-17 INTERMEDIATE OF ACCEPTABLE NON-HYGROSCOPIC FORMULATION THAT INCLUDES A HYGROSCOPIC PHARMACO

Publications (1)

Publication Number Publication Date
DOP2003000791A true DOP2003000791A (en) 2004-04-30

Family

ID=44261276

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2003000791A DOP2003000791A (en) 2003-12-17 2003-12-17 INTERMEDIATE OF ACCEPTABLE NON-HYGROSCOPIC FORMULATION THAT INCLUDES A HYGROSCOPIC PHARMACO

Country Status (1)

Country Link
DO (1) DOP2003000791A (en)

Similar Documents

Publication Publication Date Title
UY28138A1 (en) ACCEPTABLE NON-HYGROSCOPIC FORMULATION INTERMEDIATE UNDERSTANDING A HYGROSCOPIC DRUG
DE60312049D1 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHANT AGENT
DE60332393D1 (en) LIQUID PHARMACEUTICAL COMPOSITION WITH PYRIDIDE DERIVATIVES
NO20043904L (en) Oral dosage form containing an active ingredient PDE4 inhibitor and polyvinylpyrrolidone as the excipient
SV2004001473A (en) PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE PROTEIN OF TRANSFER OF ESTERES DE COLESTERILO REF.PC 23132
RS52110B (en) Dipeptidyl peptidase inhibitors for treating diabetes
ATE374016T1 (en) TABLET WITH HIGH ACTIVE INGREDIENTS
ATE541574T1 (en) SYNERGISTIC ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION FOR USE IN REDUCING PGE2-MEDIATED INFLAMMATION
ATE334656T1 (en) LIQUID PHARMACEUTICAL COMPOSITION
DE60118008D1 (en) PHARMACEUTICAL COMPOSITIONS WITH AMLODIPINMALEAT
ATE324882T1 (en) PHARMACEUTICAL COMPOSITION DISPERSIBLE IN THE ORAL CAVITY CONTAINING AGOMELATIN
ATE409485T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FAB I INHIBITORS AND OTHER ANTIBIOTICS
ATE399537T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ATORVASTATIN, PRODUCED WITHOUT GRANULATION
ATE477814T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING STABLE FACTOR-VIII
DE60305728D1 (en) PHARMACEUTICAL COMPOSITION WITH LONGER RELEASE
ATE415949T1 (en) PHARMACEUTICAL FORMULATION WITH LEVOTHYROXINE SODIUM
DK1142573T3 (en) Pharmaceutical compositions comprising faropenem sodium and a diamine acetate compound for enhancing gastrointestinal tract absorption
DE60217390D1 (en) BICALUTAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION
AR056517A1 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS USING TEMOZOLOMIDE AND AN INHIBITOR OF PROTEIN KINASE
DE60310526D1 (en) IVABRADINE-CONTAINING PHARMACEUTICAL COMPOSITION WITH ORAL DISPERSION
EP1541139A4 (en) Drug composition containing nf-kappa b inhibitor
ATE301463T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 17ALPHA-FURANYL ESTER OF 17BETA-CARBOTHIOATE ANDROSTANDE DERIVATIVES AND A MUSCARIINE RECEPTOR ANTAGONIST
MXPA05008572A (en) Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention.
DOP2003000791A (en) INTERMEDIATE OF ACCEPTABLE NON-HYGROSCOPIC FORMULATION THAT INCLUDES A HYGROSCOPIC PHARMACO
DE10291905D2 (en) Pharmaceutical composition